EU and US could reach trade deal this weekend - Reuters
NEW YORK - Goldman Sachs & Co (NYSE:GS). LLC has reported its latest trading activities involving shares of Mural Oncology PLC, indicating changes in both long and short positions as of April 15, 2025. The transactions were disclosed in compliance with the rules of the Irish Takeover Panel, which oversees trading related to company takeovers.
The financial institution’s dealings in Mural Oncology’s USD 0.01 ordinary shares have resulted in a long position of 192,567 shares, representing 1.11% of the relevant securities, and a short position of 197,092 shares, or 1.14%. These figures reflect the net position following the reported transactions.
On the day of dealing, Goldman Sachs engaged in multiple purchase transactions at prices ranging from $2.3900 to $3.0800 per share. The sales transactions were executed at prices from $2.3300 to $3.1000 per share. In addition to direct share dealings, the firm also reported derivative transactions, including CFDs (Contracts for Difference), which led to both opening new positions and reducing existing ones.
The disclosure did not reveal any agreements, arrangements, or understandings related to the voting rights of the relevant securities under any options or derivatives. The supplemental information provided with the disclosure indicated a purchased swap with an expiry date of July 8, 2025, but without further details on the number of securities it relates to or the exercise price.
This trading activity comes amid the regulatory environment that requires transparency in dealings by persons with interests in relevant securities representing 1% or more, especially in the context of potential takeovers. The information is based on a press release statement and is intended to provide a factual report of Goldman Sachs & Co. LLC’s transactions in Mural Oncology PLC securities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.